Axsome Therapeutics (AXSM) PT Raised to $250 at Oppenheimer
Oppenheimer analyst Jay Olson raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $250.00 (from $220.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)